Mipomersen - PDFSEARCH.IO - Document Search Engine

Mipomersen
Results: 19

#	Item
1	ISIS INITIATES PHASE 1 CLINICAL STUDY OF ISIS-SMNRX IN PATIENTS WITH SPINAL MUSCULAR ATROPHY U.S. FDA has granted both Fast Track Status and Orphan Drug Designation for ISIS-SMNRx CARLSBAD, Calif., December 19, 2011 – Add to Reading List Source URL: www.fsma.org.hk Language: English - Date: 2013-04-29 02:31:35 Health Spinal muscular atrophy SMN1 Mipomersen Survival of motor neuron Duchenne muscular dystrophy Amyotrophic lateral sclerosis Atrophy Muscular dystrophy Motor neurone disease Genetic genealogy Medical genetics
2	HIGHLIGHTS OF PRESCRIBING INFORMATION Add to Reading List Source URL: www.genzyme.com Language: English - Date: 2015-03-03 10:30:18 Hepatotoxicity Ezetimibe Jaundice Cirrhosis Placebo Mipomersen Niacin Elevated transaminases Alefacept Medicine Hepatology Liver function tests
3	MEDICATION GUIDE KYNAMRO® (kye-NAM-roe) (mipomersen sodium) injection Read this Medication Guide before you start using KYNAMRO and each time you get Add to Reading List Source URL: www.genzyme.com Language: English - Date: 2015-01-31 20:53:04 Chemistry Pharmaceuticals policy Organochlorides Prescription medication Lorazepam Dextropropoxyphene Hormone replacement therapy Pharmacology Medicine Drugs
4	Microsoft PowerPoint - Genzyme_Adcom_Public slides for the FDA Add to Reading List Source URL: www.fda.gov Language: English Medicine Mipomersen Low-density lipoprotein Biology Hepatitis Health Steatohepatitis
5	Endocrinologic and Metabolic Drugs Advisory Committee Meeting Silver Spring, MD 18 October[removed]FDA Review of the Nonclinical Carcinogenicity Assessment Add to Reading List Source URL: www.fda.gov Language: English Medicine Organic chemistry Antisense RNA Mipomersen Nitrazepam Dose Median lethal dose Toxicology Chemistry Organochlorides
6	MARCH/APRIL 2014 VOL. 26 NO. 2 PEER REVIEW Perspective Visibility Add to Reading List Source URL: www.cshp.org Language: English - Date: 2014-07-01 17:55:55 Health Anti-diabetic drugs Antisense RNA Mipomersen Anti-diabetic medication Pharmacist Clinical trial Pharmacy Food and Drug Administration Pharmaceutical sciences Medicine Pharmacology
7	Microsoft PowerPoint - Mipo_Core Presentation_10_18_12_FINAL SHOW FILE Add to Reading List Source URL: www.fda.gov Language: English Cardiology Lipoproteins Apolipoproteins Mipomersen Low-density lipoprotein Cholesterol High-density lipoprotein Familial hypercholesterolemia Apolipoprotein B Medicine Chemistry Biology
8	Back-up Slides Ronald Wange, Ph.D. EMDAC October 18, 2012 meeting 18 October 2012 Add to Reading List Source URL: www.fda.gov Language: English Magnesium in biology MG Cars 42 Isis Wange Isis Biology Antisense RNA Mipomersen
9	FDA Briefing Document NDA[removed]Mipomersen Sodium Injection 200 mg/mL Applicant: Genzyme Corporation Add to Reading List Source URL: www.fda.gov Language: English Cardiology Lipoproteins Clinical research Pharmacology Antisense RNA Mipomersen Low-density lipoprotein Clinical trial High-density lipoprotein Medicine Health Biology
10	Microsoft Word - FINAL POSTING Questions EMDAC[removed]Mipomersen.docx Add to Reading List Source URL: www.fda.gov Language: English Medicine Lipoproteins Apolipoproteins Antisense RNA Mipomersen Familial hypercholesterolemia Low-density lipoprotein Hypercholesterolemia Apolipoprotein B Cardiology Biology Chemistry